Has MRD monitoring superseded other prognostic factors in adult ALL?

Abstract excerpt

Significant improvements have been made in the treatment of acute lymphoblastic leukemia (ALL) during the past 2 decades, and measurement of submicroscopic (minimal) levels of residual disease (MRD) is increasingly used to monitor treatment efficacy. For a better comparability of MRD data, there are ongoing efforts to standardize MRD quantification using real-time quantitative PCR of clonal immunoglobulin and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Flow Cytometry
• Share to Fusion Proteins, bcr-abl
• Share to Gene Rearrangement